glp-1 receptor agonist type 1 diabetes trial liraglutide glp-1_analogs [TUSOM Oral GLP-1-Based Therapeutics in the
Description
The improvement of IIH with GLP-1 RAs is promising, but prospective, randomized controlled trials with larger cohorts are needed
However, dose-dependent gastrointestinal effects limit efficacy, so drugs with GLP-1 and GCG pharmacology can also target alternative pathways and may expand the therapeutic index (132)
10.1016/j.drugalcdep.2017.07.033 7 CagniardB.MurphyN
START YOUR BASELINE Most of what we write about here shows up in your blood work
JAMA Neurol 78(6):678686 Witry M et al (2021) The patients perspective on the burden of idiopathic intracranial hypertension
Bjerre Knudsen, L
